ACLX Stock Cash Flow Statements

Arcellx Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Arcellx Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31

cash flows from operating activities
net income	-52,771,000	-62,270,000	-47,081,000	-25,867,000	-27,202,000	-7,198,000	19,844,000	-39,336,000	-23,854,000	-27,344,000	-38,992,000	-85,211,000	-32,091,000	-32,385,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	1,618,000	1,576,000	1,789,000	1,334,000	1,239,000	826,000	722,000	447,000	439,000	432,000	417,000	339,000	149,000	416,000
non-cash operating lease expense	188,000	186,000		131,000	131,000	2,903,000
right-of-use asset expensed			-94,000	0	50,000	838,000	624,000			1,705,000
amortization of premiums and discounts on marketable securities	-2,397,000	-3,136,000	-3,568,000	-3,404,000	-4,127,000	-4,360,000	-3,944,000	-2,415,000	-2,711,000	-1,978,000	-1,357,000	-806,000	-72,000	110,000
share-based compensation	18,076,000	23,817,000	15,769,000	15,333,000	15,139,000	14,845,000	10,615,000	10,614,000	10,404,000	10,156,000	5,790,000	5,329,000	5,944,000	4,481,000
changes in operating assets and liabilities:
prepaid expenses and other current and non-current assets	-98,000	1,719,000	982,000	353,000	562,000	6,714,000	6,632,000	1,826,000	-11,886,000	-4,931,000	-1,545,000	13,683,000	-9,410,000	-8,423,000
accounts payable and other current liabilities	-2,288,000	2,241,000	-3,584,000	908,000	2,299,000	307,000	-4,826,000	2,149,000	440,000	-4,237,000	5,925,000	-4,173,000	4,971,000	696,000
accrued liabilities	9,639,000	-13,231,000	14,376,000	954,000	9,004,000	17,675,000	7,013,000	176,000	-1,423,000	-173,000	282,000	-10,740,000	7,500,000	2,563,000
operating lease liabilities	-678,000	-659,000	-617,000	-604,000	-567,000	-1,979,000	-422,000	3,602,000	9,268,000	1,013,000	2,113,000	865,000	249,000	-104,000
contract liability to related party	-7,583,000	-8,232,000	-17,432,000	41,432,000	-32,208,000	-77,946,000
other non-current liabilities	-3,437,000	-5,156,000	-6,455,000	149,000	-569,000	15,468,000
net cash from operating activities	-39,731,000	-63,145,000	-46,030,000	30,719,000	-36,249,000	-31,907,000	58,248,000	-10,102,000	-22,615,000	182,042,000	-27,520,000	-16,649,000	-22,548,000	-32,586,000
capex	-452,000	-553,000	-2,508,000	-2,026,000	-4,652,000	-3,923,000	-10,658,000	-4,044,000	-6,614,000	1,729,000	-936,000	10,000	-149,000	-432,000
free cash flows	-40,183,000	-63,698,000	-48,538,000	28,693,000	-40,901,000	-35,830,000	47,590,000	-14,146,000	-29,229,000	183,771,000	-28,456,000	-16,639,000	-22,697,000	-33,018,000
cash flows from investing activities
purchases of property and equipment	-487,000	-780,000	-1,499,000	-2,290,000	-3,213,000	-6,432,000	-5,293,000	-7,927,000	-7,228,000	-980,000	-1,276,000	-385,000	-149,000	-467,000
purchases of marketable securities	-156,572,000	-78,636,000	-136,321,000	-59,950,000	-82,660,000	-318,380,000	-42,385,000	-237,900,000	0	-162,144,000	-25,757,000	-128,606,000	-92,348,000	-27,026,000
proceeds from maturities of marketable securities	167,800,000	117,200,000	133,700,000	98,000,000	78,000,000	118,000,000	68,695,000	85,800,000	58,500,000	96,350,000	60,655,000	47,571,000	33,264,000	16,850,000
net cash from investing activities	10,741,000	37,784,000	-4,120,000	35,760,000	-7,873,000	-206,812,000	21,017,000	-160,027,000	51,272,000	-66,774,000	33,622,000	-81,420,000	-59,233,000	-10,643,000
cash flows from financing activities
proceeds from issuance of common stock in offerings, net of transactions costs
proceeds from exercise of stock options	1,675,000	772,000		3,697,000	2,289,000	4,604,000		1,242,000	2,966,000	374,000		344,000
proceeds from stock issued pursuant to employee stock purchase plan				0
principal payments under finance leases	-1,000	-229,000		-8,355,000	-13,362,000	-7,589,000
net cash from financing activities	10,257,000	543,000	-6,017,000	-4,658,000	-10,427,000	-2,985,000	188,591,000	-4,989,000	116,000	95,445,000	1,314,000	-9,708,000	121,463,000	139,556,000
net decrease in cash and cash equivalents and restricted cash	-18,733,000	-24,818,000
cash and cash equivalents and restricted cash, beginning of the period	0	108,305,000		0	0	398,904,000
cash and cash equivalents and restricted cash, end of the period	-18,733,000	83,487,000	-56,167,000	61,821,000	-54,549,000	157,200,000	267,856,000	-175,118,000	28,773,000	277,393,000	7,416,000	-107,777,000	39,682,000	127,359,000
supplemental disclosure of cash flow information:
cash paid for income taxes			168,000	401,000			0	0
supplemental disclosures of noncash investing and financing activities:
purchase of property and equipment included in accounts payable and accrued liabilities	35,000	227,000	-1,009,000	264,000	-1,439,000	2,509,000	-5,365,000	3,883,000	614,000	2,709,000	340,000	395,000	0	35,000
loss on disposal of property and equipment											2,000
noncash operating lease expense							197,000			310,000	310,000	321,000	212,000	60,000
proceeds from issuance of common stock (initial public offering), net of transactions costs											0	0	0	129,156,000
proceeds from issuance of common stock in private placement, net of transactions costs
proceeds from issuance of common stock (follow-on offering), net of transactions costs											0	-816,000
proceeds from exercise of stock options and early exercise of restricted stock
proceeds from issuance of common stock under the employee stock purchase plan
payments under finance leases							-15,382,000	-5,703,000	-3,378,000	-4,929,000			-30,000	-29,000
net increase in cash and cash equivalents and restricted cash			-56,167,000	61,821,000	-54,549,000	-241,704,000	267,856,000	-175,118,000	28,773,000	210,713,000	7,416,000	-107,777,000	39,682,000	96,327,000
cash and cash equivalents and restricted cash, beginning of the year							0	0	0	66,680,000	0	0	0	31,032,000
supplemental disclosures of cash flow information:
receivable from collaboration partner								-2,049,000	-8,201,000	-21,230,000
proceeds from issuance of common stock in accordance with gilead stock purchase agreement								0	0	100,000,000
proceeds from issuance of series c redeemable convertible preferred stock, net of transaction costs
payments for repurchase of restricted stock
payments under capital leases
payments of deferred offering costs
deferred offering costs included in accounts payable and accrued liabilities
contract liability								-2,345,000	5,093,000	228,319,000
proceeds from issuance of common stock (private placement), net of transactions costs											0	0	-42,000	10,000,000
amortization of operating lease right-of-use assets
finance lease right-of-use asset expensed
deferred rent
interest expense
right of use asset expensed
payments under finance lease
proceeds from the exercise of stock options														429,000
deferred offering costs included in accrued liabilities														42,000
payment for repurchase of restricted stock
proceeds from issuance of series b redeemable convertible preferred stock, net of transaction costs
net increase in cash, cash equivalents and restricted cash
cash, cash equivalents and restricted cash, beginning of the year
cash, cash equivalents and restricted cash, end of the period

We provide you with 20 years of cash flow statements for Arcellx stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Arcellx stock. Explore the full financial landscape of Arcellx stock with our expertly curated income statements.

The information provided in this report about Arcellx stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.